PARIS and TARRYTOWN, N.Y., March 2, 2013 /PRNewswire/ – Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that pooled data from two Phase 1b trials with dupilumab (REGN668/SAR231893), an investigational, high-affinity,…
PR Newswire: Health